Rapid Micro Biosystems Inc Class A RPID
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Rapid Micro Biosystems to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
-
Rapid Micro Biosystems Reports Second Quarter 2024 Financial Results
-
Rapid Micro Biosystems to Announce Second Quarter 2024 Financial Results on August 2, 2024
-
Rapid Micro Biosystems Shares Rise After Samsung Biologics Partnership
Trading Information
- Previous Close Price
- $0.85
- Day Range
- $0.85–0.92
- 52-Week Range
- $0.58–1.18
- Bid/Ask
- $0.87 / $0.95
- Market Cap
- $38.54 Mil
- Volume/Avg
- 53,170 / 61,162
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.53
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 193
- Website
- https://www.rapidmicrobio.com
Valuation
|
Metric
|
RPID
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.40 |
Price/Sales | 1.53 |
Price/Cash Flow | — |
Price/Earnings
RPID
Financial Strength
|
Metric
|
RPID
|
|---|---|
Quick Ratio | 4.50 |
Current Ratio | 5.92 |
Interest Coverage | — |
Quick Ratio
RPID
Profitability
|
Metric
|
RPID
|
|---|---|
Return on Assets (Normalized) | −33.52% |
Return on Equity (Normalized) | −40.01% |
Return on Invested Capital (Normalized) | −40.21% |
Return on Assets
RPID
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Frshvxnsg | Gzrfgr | $196.1 Bil | |||
| Stryker Corp
SYK
| Kglpntcfb | Czkx | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Pmsgxgmp | Lcvwqg | $122.3 Bil | |||
| Medtronic PLC
MDT
| Sgrmgkcqt | Gbbpyq | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Fkctdhtxt | Hrmbntv | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Psqpy | Dgny | $29.1 Bil | |||
| DexCom Inc
DXCM
| Dyzhphxf | Rwcwc | $27.1 Bil | |||
| Steris PLC
STE
| Chzwywf | Rflsdn | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Mtdmlsxyk | Qnq | $21.9 Bil | |||
| Insulet Corp
PODD
| Lhcvtqbnd | Dbxxgz | $16.5 Bil |
United States